Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
ReWalk Robotics Ltd is a medical devices business based in the US. ReWalk Robotics shares (RWLK) are listed on the NASDAQ and all prices are listed in US Dollars. ReWalk Robotics employs 49 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$0.41 - $5.50|
|50-day moving average||$3.04|
|200-day moving average||$1.72|
|Wall St. target price||$3.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-6.12|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Revenue TTM||$4.4 million|
|Gross profit TTM||$2.2 million|
|Return on assets TTM||-28.61%|
|Return on equity TTM||-79.72%|
|Market capitalisation||$134.2 million|
TTM: trailing 12 months
There are currently 3.3 million ReWalk Robotics shares held short by investors – that's known as ReWalk Robotics's "short interest". This figure is 309.9% up from 800,291 last month.
There are a few different ways that this level of interest in shorting ReWalk Robotics shares can be evaluated.
ReWalk Robotics's "short interest ratio" (SIR) is the quantity of ReWalk Robotics shares currently shorted divided by the average quantity of ReWalk Robotics shares traded daily (recently around 4.3 million). ReWalk Robotics's SIR currently stands at 0.77. In other words for every 100,000 ReWalk Robotics shares traded daily on the market, roughly 770 shares are currently held short.
However ReWalk Robotics's short interest can also be evaluated against the total number of ReWalk Robotics shares, or, against the total number of tradable ReWalk Robotics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ReWalk Robotics's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 ReWalk Robotics shares in existence, roughly 70 shares are currently held short) or 0.0741% of the tradable shares (for every 100,000 tradable ReWalk Robotics shares, roughly 74 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ReWalk Robotics.
Find out more about how you can short ReWalk Robotics stock.
We're not expecting ReWalk Robotics to pay a dividend over the next 12 months.
ReWalk Robotics's shares were split on a 1:25 basis on 31 March 2019. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ReWalk Robotics shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for ReWalk Robotics shares which in turn could have impacted ReWalk Robotics's share price.
Over the last 12 months, ReWalk Robotics's shares have ranged in value from as little as $0.41 up to $5.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ReWalk Robotics's is 3.4843. This would suggest that ReWalk Robotics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
ReWalk Robotics Ltd. , a medical device company, designs, develops, and commercializes wearable robotic exoskeletons for individuals with mobility impairments or other medical conditions in Israel, the United States, Europe, the Asia-Pacific, Latin America, and Africa. It offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for used in the rehabilitation of individuals with lower limb disability due to stroke; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers, institutions, and individuals, as well as through distributors. The company was formerly known as Argo Medical Technologies Ltd. and changed its name to ReWalk Robotics Ltd. ReWalk Robotics Ltd.
Everything we know about the TC Bancshares IPO, plus information on how to buy in.
Everything we know about the Soulgate IPO, plus information on how to buy in.
Everything we know about the Alzamend Neuro IPO, plus information on how to buy in.
Everything we know about the Singular Genomics Systems IPO, plus information on how to buy in.
Everything we know about the Golden Sun Education Group Limited IPO, plus information on how to buy in.
Everything we know about the Phillips Edison & Company IPO, plus information on how to buy in.
Everything we know about the FIGS IPO, plus information on how to buy in.
Everything we know about the DLocal Limited IPO, plus information on how to buy in.
Everything we know about the Torchy’s Tacos IPO, plus information on how to buy in.
Everything we know about the Dutch Bros Coffee IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.